Business Description
Eco Animal Health Group PLC
ISIN : GB0032036807
Description
Eco Animal Health Group PLC is engaged in the manufacture and marketing of animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The geographical segments of the company include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.56 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.62 | |||||
| Interest Coverage | 5.39 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.04 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.1 | |||||
| 3-Year EBITDA Growth Rate | -33 | |||||
| 3-Year EPS without NRI Growth Rate | -41.3 | |||||
| 3-Year FCF Growth Rate | -24.6 | |||||
| 3-Year Book Growth Rate | 0.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.25 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.81 | |||||
| 9-Day RSI | 10.29 | |||||
| 14-Day RSI | 16.81 | |||||
| 6-1 Month Momentum % | 15.91 | |||||
| 12-1 Month Momentum % | 14.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.96 | |||||
| Quick Ratio | 2.29 | |||||
| Cash Ratio | 0.89 | |||||
| Days Inventory | 138.41 | |||||
| Days Sales Outstanding | 109.39 | |||||
| Days Payable | 73.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.25 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.14 | |||||
| Operating Margin % | 4.61 | |||||
| Net Margin % | 1.17 | |||||
| FCF Margin % | 5.36 | |||||
| ROE % | 1.27 | |||||
| ROA % | 0.87 | |||||
| ROIC % | 3.22 | |||||
| ROC (Joel Greenblatt) % | 10.15 | |||||
| ROCE % | 3.85 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 71.25 | |||||
| Forward PE Ratio | 51.81 | |||||
| PE Ratio without NRI | 71.25 | |||||
| Shiller PE Ratio | 12.02 | |||||
| Price-to-Owner-Earnings | 23.27 | |||||
| PS Ratio | 0.88 | |||||
| PB Ratio | 0.92 | |||||
| Price-to-Tangible-Book | 1.6 | |||||
| Price-to-Free-Cash-Flow | 16.29 | |||||
| Price-to-Operating-Cash-Flow | 8.38 | |||||
| EV-to-EBIT | 14.57 | |||||
| EV-to-Forward-EBIT | 10.68 | |||||
| EV-to-EBITDA | 8.33 | |||||
| EV-to-Forward-EBITDA | 7.17 | |||||
| EV-to-Revenue | 0.61 | |||||
| EV-to-Forward-Revenue | 0.6 | |||||
| EV-to-FCF | 12.28 | |||||
| Price-to-Projected-FCF | 0.66 | |||||
| Price-to-Median-PS-Value | 0.24 | |||||
| Price-to-Graham-Number | 2.19 | |||||
| Price-to-Net-Current-Asset-Value | 2.07 | |||||
| Earnings Yield (Greenblatt) % | 6.86 | |||||
| FCF Yield % | 6.59 | |||||
| Forward Rate of Return (Yacktman) % | -8.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eco Animal Health Group PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 89.422 | ||
| EPS (TTM) (£) | 0.016 | ||
| Beta | 0.93 | ||
| Volatility % | 41.03 | ||
| 14-Day RSI | 16.81 | ||
| 14-Day ATR (£) | 0.040264 | ||
| 20-Day SMA (£) | 1.21525 | ||
| 12-1 Month Momentum % | 14.86 | ||
| 52-Week Range (£) | 0.82665 - 1.35 | ||
| Shares Outstanding (Mil) | 67.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eco Animal Health Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eco Animal Health Group PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eco Animal Health Group PLC Frequently Asked Questions
What is Eco Animal Health Group PLC(LSE:EAH)'s stock price today?
The current price of LSE:EAH is £1.08. The 52 week high of LSE:EAH is £1.35 and 52 week low is £0.83.
When is next earnings date of Eco Animal Health Group PLC(LSE:EAH)?
The next earnings date of Eco Animal Health Group PLC(LSE:EAH) is 2024-11-27 Est..
Does Eco Animal Health Group PLC(LSE:EAH) pay dividends? If so, how much?
Eco Animal Health Group PLC(LSE:EAH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers